Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis

doi:10.3748/wjg.v13.i8.1208

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2863)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

246

HTML

2149

Figures (1-5)

263

Tables (1-2)

205

Sum=2863

Feb 28, 2007 (publication date) through Jan 23, 2025

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 28, 2007; 13(8): 1208-1213
Published online Feb 28, 2007. doi: 10.3748/wjg.v13.i8.1208

Full Size Figure Download Figure

Figure 3 Angiogenesis in normal chick CAM (A), HepG2-induced CAM (B), and HepG2-induced CAM treated with 0. 4 μmol/L MK-AS (C). Chick CAM assays were used to assess the impact of MK-AS on angiogenesis in vivo.

Citation: Dai LC, Wang X, Yao X, Lu YL, Ping JL, He JF. Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis. World J Gastroenterol 2007; 13(8): 1208-1213
URL: https://www.wjgnet.com/1007-9327/full/v13/i8/1208.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i8.1208